Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0AE5G
|
|||
Drug Name |
Phthalazine derivative 2
|
|||
Synonyms |
PMID27841036-Compound-15
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Janssen Pharmaceutica NV
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H24FN3O3
|
|||
Canonical SMILES |
C1CN(CCC1C2=NNC(=O)C3=CC=CC=C32)CC(COC4=CC=C(C=C4)F)O
|
|||
InChI |
1S/C22H24FN3O3/c23-16-5-7-18(8-6-16)29-14-17(27)13-26-11-9-15(10-12-26)21-19-3-1-2-4-20(19)22(28)25-24-21/h1-8,15,17,27H,9-14H2,(H,25,28)
|
|||
InChIKey |
KVBJGGXSNXZAOH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Poly [ADP-ribose] polymerase (PARP) | Target Info | Inhibitor | [1] |
Target's Patent Info | Poly [ADP-ribose] polymerase (PARP) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | PARP inhibitors as antitumor agents: a patent update (2013-2015).Expert Opin Ther Pat. 2017 Mar;27(3):363-382. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.